Trending...
- Chicago: Mayor Brandon Johnson Welcomes Metropolitan Mayors Caucus, Builds on Bipartisan Coalition That Held the Line on Local Government Funding
- WCIA 3's Kevin Lighty to Interview Aerostratospheric President Jeremy Higgs on Behind the Forecast
- Cress Creeks Farm Opens Fall Corn Maze and Baby Lamb Hayride Experience in Ellijay, Georgia
Lilly joins ReFRAME at Scripps Research/Calibr and CURE ID at the FDA and NCATS/NIH
CHICAGO - illiNews -- Cures Within Reach today announced Eli Lilly and Company as the recipient of the 2021 Patient Impact Industry Award, part of its Global Health Repurposing Awards. The award recognizes Lilly's work to treat COVID-19 patients using medication that is already approved for other treatments, among other diseases.
Cures Within Reach celebrates and honors Lilly's ongoing commitment to improving the lives of patients with unmet medical needs. During the COVID-19 pandemic, this has been through its support of baricitinib, an existing rheumatoid arthritis medication, to treat certain hospitalized COVID-19 patients, among other initiatives. Baricitinib has been authorized for emergency use by the FDA in combination with remdesivir.
"Like many around the world, Lilly has worked tirelessly since the start of the pandemic to help those impacted by COVID-19," said Robert Baker, Lilly's Deputy Chief Medical Officer. "These efforts included evaluating the potential of our existing medicines to treat complications of COVID-19. We are honored to be recognized by Cures Within Reach for using our medicines to address unmet needs and significantly impact patients' lives."
More on illi News
In addition, Lilly has continued to test already approved therapies for new indications, including duloxetine for fibromyalgia and ramucirumab for various cancers after it was first approved for stomach cancer.
Earlier this year, Cures Within Reach announced two other winners of its 2021 Global Health Repurposing Awards. They are:
"These important contributions to improving the quality of life for patients who often feel hopeless should be recognized," said Barbara Goodman, President & CEO of Cures Within Reach. "The COVID-19 pandemic has spotlighted the advantages of testing already approved therapies and the need to further fund research and development for other unsolved diseases."
More on illi News
For more information on these awardees, upcoming events and CWR, visit http://bit.ly/cwrghra2021
About Cures Within Reach
Cures Within Reach (CWR) is a US-based philanthropic leader improving patient quality and length of life by leveraging the speed, safety and cost-effectiveness of medical repurposing research: driving more treatments to more patients more quickly. CWR catalyzes research to facilitate and validate already approved therapies for new indications to create clinical impact. CWR isn't funding to the regulatory "finish line," but providing seed funds to achieve catalytic effect. CWR's 2021 initiatives include focused efforts to impact Pediatrics; Veterans; and Diversity, Equity & Inclusion efforts. CWR currently has a global portfolio of 33 repurposing research projects at 28 institutions in 21 diseases. Visit cureswithinreach.org (http://www.cureswithinreach.org/).
Cures Within Reach celebrates and honors Lilly's ongoing commitment to improving the lives of patients with unmet medical needs. During the COVID-19 pandemic, this has been through its support of baricitinib, an existing rheumatoid arthritis medication, to treat certain hospitalized COVID-19 patients, among other initiatives. Baricitinib has been authorized for emergency use by the FDA in combination with remdesivir.
"Like many around the world, Lilly has worked tirelessly since the start of the pandemic to help those impacted by COVID-19," said Robert Baker, Lilly's Deputy Chief Medical Officer. "These efforts included evaluating the potential of our existing medicines to treat complications of COVID-19. We are honored to be recognized by Cures Within Reach for using our medicines to address unmet needs and significantly impact patients' lives."
More on illi News
- Jeron Continues to Invest in Technology to Meet Growing Demands
- Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple
- Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
- Gary Bernstein Expands Media Leadership Role With Senior Strategic Advisor Appointment To Blacksun Private Equity
- Litera Brings Foundation Firm AI Search into ChatGPT with Plugin
In addition, Lilly has continued to test already approved therapies for new indications, including duloxetine for fibromyalgia and ramucirumab for various cancers after it was first approved for stomach cancer.
Earlier this year, Cures Within Reach announced two other winners of its 2021 Global Health Repurposing Awards. They are:
- ReFRAME at Scripps Research/Calibr is the recipient of the 2021 Janet Davison Rowley Patient Impact Research Award
- CURE ID at the FDA and NCATS/NIH is the recipient of the 2021 Golan Christie Taglia Patient Impact Philanthropy Award
"These important contributions to improving the quality of life for patients who often feel hopeless should be recognized," said Barbara Goodman, President & CEO of Cures Within Reach. "The COVID-19 pandemic has spotlighted the advantages of testing already approved therapies and the need to further fund research and development for other unsolved diseases."
More on illi News
- Headline: House of Nova Paints Every Face in Gold at New York Fashion Week
- Can Government Operate Better Through Innovation?
- Michael H. Kaplan Advocates for Seriously Injured Colorado Workers Who Need In-Home Care
- Just Right Armrest Introduces an Adjustable Approach to Vehicle Arm Support
- Wig Floater Introduces a Convenient Magnetic Hanging Solution for Wig Storage
For more information on these awardees, upcoming events and CWR, visit http://bit.ly/cwrghra2021
About Cures Within Reach
Cures Within Reach (CWR) is a US-based philanthropic leader improving patient quality and length of life by leveraging the speed, safety and cost-effectiveness of medical repurposing research: driving more treatments to more patients more quickly. CWR catalyzes research to facilitate and validate already approved therapies for new indications to create clinical impact. CWR isn't funding to the regulatory "finish line," but providing seed funds to achieve catalytic effect. CWR's 2021 initiatives include focused efforts to impact Pediatrics; Veterans; and Diversity, Equity & Inclusion efforts. CWR currently has a global portfolio of 33 repurposing research projects at 28 institutions in 21 diseases. Visit cureswithinreach.org (http://www.cureswithinreach.org/).
Source: Cures Within Reach
Filed Under: Health
0 Comments
Latest on illi News
- Mom Era, Still That Girl: Family Art Tees 25% Off
- Fashion vs. Fascism - Because Democracy Should Always Be In Style
- Mayor Brandon Johnson, CDOT, and LYFT Announce Divvy's Busiest Summer Ever as Biking Continues to Boom in Chicago
- Chicago: Mayor Brandon Johnson Announces Appointments to Department of Fleet and Facility Management and Department of Human Resources
- Lee Gunn IV Shares Lessons From 40 Years in the Courtroom on PodNumbra Podcast
- Michael H. Kaplan Recognized for 17 Years on PHPA Workers' Compensation Panel and Advocacy for Professional Athletes
- International Society of Medical AI Convenes Global Faculty in Florence for ISMAI 2026
- Boston Industrial Solutions Introduces Personalized Printing Training
- OnDemand Launches Craft Coffee and Pantry as the Next Step in Its Growing Amenity Platform
- Century Fasteners de Mexico Exhibiting at the 2026 Automotive & Aerospace Nearshoring Summit
- Northeast Airlines aligns with European Investment Group
- Retell AI White Label Platform for Agencies Launched by VoiceAIWrapper, With Branded Client Portals and No Per-Minute Markup
- FOCUS Names Mark Phillips Senior Vice President of Business Development
- STLE's Interactive Lubrication Training Experience Returns to Southwest Research Institute
- Notaron Expands Online Notarization Access Following Wisconsin Approval
- Mondo teams up with Paragon Sports Constructors as official outdoor track partner for Texas
- Exercise Scientist Turns a Personal Heart Scare into a Free Training Tool
- Wings Air Helicopters Selected to Support VIP Transportation for Resorts World in New York
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Houston This October
- Chicago: Mayor Brandon Johnson, Department of Technology and Innovation Launch Revamped Mayor's Office Website